Fecal Biomarker Study for Patients With Ulcerative Colitis | NCT00780507 | Trialant

Fecal Biomarker Study for Patients With Ulcerative Colitis | NCT00780507 | Trialant

Outcomes Module

Primary Outcomes

Measure	Description	Time Frame
Compare the fecal biomarker calprotectin between the UC patients who relapse (flare) and the UC patients who remain in remission throughout the study while on Asacol regardless of the maintenance regimen.		one year

Secondary Outcomes

Measure	Description	Time Frame
To compare the fecal levels of the 2 biomarkers (FC and FL) in patients who are on BID and QD treatment regimens and who remain in remission for the duration of the study;		one year

Contacts/Locations Module

Ancestor Terms

ID	Term
D003092	Colitis
D005759	Gastroenteritis
D005767	Gastrointestinal Diseases
D004066	Digestive System Diseases
D015212	Inflammatory Bowel Diseases
D003108	Colonic Diseases
D007410	Intestinal Diseases